Summary:
Respiratory virus infections are an important cause of morbidity and mortality in bone marrow transplant patients. A retrospective study was performed on the bone marrow transplant unit at the Christie Hospital Manchester. The aim of this study was to determine the frequency, clinical presentation, laboratory diagnosis, types of intervention (eg antiviral agents used) and the outcome of such infections in this cohort of transplant recipients. Data were collected from a total of 626 adult patients and showed 27 patients with 29 confirmed episodes of viral respiratory tract infections. The viruses present were rhinovirus (40%), respiratory syncytial virus (RSV) (22.2%), influenza A (18.5%), parainfluenza (PIV) (14.8%) and enteroviruses (7.4%). The overall frequency of documented respiratory virus infections was 4.3% during the 5-year period of the study. The prevalence of respiratory viral infections was 7.8% among allogeneic and 2.3% among autologous transplant recipients. The frequency of lower respiratory tract infection (LRTI) was 3.0% among allogeneic and 1.3% among autologous transplant recipients. Eight patients died (seven had allogeneic transplants). Three of these deaths were directly attributable to a respiratory viral infection (two rhinoviruses; one PIV 3). This study further supports the role played by human respiratory viruses in transplant-associated morbidity and mortality, and particularly highlights the significance of rhinovirus infections.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Ljungman P, Ward KN, Crooks BNA et al. Respiratory virus infections after stem cell transplantation: a prospective study from the Infectious Diseases Working Party of the European Group for Blood and Marrow Transplantation. Bone Marrow Transplant 2001; 28: 479–484.
Bowden RA . Respiratory virus infections after marrow transplant: the Fred Hutchinson Cancer Research Centre experience. Am J Med 1997; 102 (Suppl. 3a): 27–30.
Ljungman P . Respiratory virus infections in bone marrow transplant recipients: the European perspective. Am J Med 1997; 102: 44–48.
Whimbey E, Champlin RE, Couch RB et al. Community respiratory virus infections among hospitalised adult bone marrow transplant recipients. Clin Infect Dis 1996; 22: 778–782.
Ghosh S, Champlin R, Couch R et al. Rhinovirus infections in myelosuppressed adult blood and marrow transplant recipients. Clin Infect Dis 1999; 29: 528–532.
Lennette EH, Schmidt NJ (eds). Diagnostic Procedures for Viral, Rickettsial and Chlamydial Infections, 5th ed. APHA: Washington DC, 1979.
Malcolm E, Arruda E, Hayden F et al. Clinical features of patients with acute respiratory illness and rhinovirus in their bronchoalveolar lavages. J Clin Virol 2001; 21: 9–16.
Papadopoulos N, Bates P, Bardin P et al. Rhinoviruses infect the lower airways. J Infect Dis 2000; 181: 1875–1884.
Imakita M, Shiraki K, Yutani C et al. Pneumonia caused by rhinoviruses. Clin Infect Dis 2000; 30: 611–612.
Mosser AG, Brockman-Schneider R, Amineva S et al. Similar frequency of rhinovirus-infectible cells in upper and lower airway epithelium. J Infect Dis 2002; 185: 734–743
Whimbey E, Champlin RE, Englund JA et al. Combination therapy with aerosolized ribavirin and intravenous immunoglobulin for respiratory syncytial virus disease in adult bone marrow transplant recipients. Bone Marrow Transplant 1995; 16: 393–399.
Ghosh S, Champlin RE, Englund J et al. Respiratory syncytial virus upper respiratory tract illnesses in adult blood and marrow transplant recipients: combination therapy with aerosolized ribavirin intravenous immunoglobulin. Bone Marrow Transplant 2000; 25: 751–755.
DeVincenzo JP, Hirsch RL, Fuentes RJ, Top Jr FH . Respiratory syncytial virus immune globulin treatment of lower respiratory tract infection in paediatric patients, undergoing bone marrow transplantation—a compassionate use experience. Bone Marrow Transplant 2000; 25: 161–165.
McColl MD, Corser RB, Bremner J, Chopra R . Respiratory syncytial virus infection in adult BMT recipients: effective therapy with short duration nebulised ribavirin. Bone Marrow Transplant 1998; 21: 423–425.
McCarthy AJ, Kingman HM, Kelly C et al. The outcome of 26 patients with respiratory syncytial virus infection following allogeneic stem cell transplantation. Bone Marrow Transplant 1999; 24: 1315–1322.
Whimbey E, Elting LS, Couch RB et al. Influenza A virus infections among hospitalised adult bone marrow transplant recipients. Bone Marrow Transplant 1994; 13: 437–440.
Robertson JD, Nagesh K, Jowitt SN et al. Immunogenicity of vaccination against influenza, Streptococcus pneumoniae and Haemophilus influenzae type B in patients with multiple myeloma. Br J Cancer 2000; 82: 1261–1265.
Lewis A, Champlin R, Englund J et al. Respiratory disease due to parainfluenza virus in adult bone marrow transplant recipients. Clin Infect Dis 1996; 23:1033–1037.
Schmid ML, Kudesia G, Wake S, Read RC . Prospective comparative study of culture specimens and methods in diagnosing influenza in adults. BMJ 1998; 316: 275.
Whimbey E, Englund JA, Couch R . Community respiratory viral infections in immunocompromised patients with cancer. Am J Med 1997; 102: 10–18.
van Elden LJR, van Kraaij MGJ, Nijhuis M et al. Polymerase chain reaction is more sensitive than viral culture and antigen testing for the detection of respiratory viruses in adults with haematological cancer and pneumonia. Clin Infect Dis 2002; 34: 177–183.
Snell NJC . New treatments for viral respiratory tract infections—opportunities and problems. J Antimicrob Chemother 2001; 47: 251–259.
Hsyu P-H, Pithavala YK, Gersten M et al. Pharmacokinetics and safety of an antirhinoviral agent, ruprintrivir, in healthy volunteers. Antimicrob Agents Chemother 2002; 46: 392–397.
Acknowledgements
We are grateful to Barbara Foulkes (Senior Data Manager) at the Christie Hospital for her assistance.
Author information
Authors and Affiliations
Additional information
An abstract of this work was accepted for oral presentation at the European Conference on Viral Diseases (ConVir 2002), Munich, Germany (10–12th May 2002).
Rights and permissions
About this article
Cite this article
Hassan, I., Chopra, R., Swindell, R. et al. Respiratory viral infections after bone marrow/peripheral stem-cell transplantation: the Christie hospital experience1. Bone Marrow Transplant 32, 73–77 (2003). https://doi.org/10.1038/sj.bmt.1704048
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.bmt.1704048
Keywords
This article is cited by
-
Impact of FilmArrayâ„¢ Respiratory Panel testing on the clinical management of pediatric bone marrow transplant patients
European Journal of Clinical Microbiology & Infectious Diseases (2022)
-
Evaluation of prognostic scores for respiratory syncytial virus infection in a French multicentre cohort of allogeneic haematopoietic stem cell transplantation recipients
Bone Marrow Transplantation (2021)
-
Community acquired respiratory virus infections in adult patients undergoing umbilical cord blood transplantation
Bone Marrow Transplantation (2020)
-
Microbiome: An Emerging New Frontier in Graft-Versus-Host Disease
Digestive Diseases and Sciences (2019)
-
Outcomes of hematopoietic SCT recipients with rhinovirus infection: a matched, case–control study
Bone Marrow Transplantation (2013)